Drugs Information: Panitumumab
Basic Information
|
||
| ID | DDInter1386 | |
| Drug Type | biotech | |
| Molecular Formula | None | |
| Molecular Weight | - | |
| Description | Panitumumab is a recombinant humanized monoclonal antibody used to treat EGFR-expressing, metastatic colorectal carcinoma that is refractory to fluoropyrimidine-, oxaliplatin-, and irinotecan- containing chemotherapy regimens. | |
| ATC Classification | L01XC08 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Panitumumab
| Severity level | ID | Name | Mechanism | Detail |
|---|